桑福德伯纳姆普利贝斯医学研究所2023年毕业生分布 桑福德伯纳姆普利贝斯医学研究所 Sanford Burnham Prebys Medical Discovery Institute 学生组成: 研究生2024年 桑福德伯纳姆普利贝斯医学研究所 Sanford Burnham Prebys Medical Discovery Institute 学生年齡分布: 研究生 22-2425-2930-3435-3940-49161412108202468...
Sanford Burnham Prebys Medical Discovery Institute (SBP) is an independent nonprofit medical research organization that conducts world-class, collaborative, biological research and translates its discoveries for the benefit of patients. SBP focuses its research on cancer, immunity, neurodegene...
Export Citation: Click for automatic bibliography generation Assignee: Sanford Burnham Prebys Medical Discovery Institute Tumorgen, Inc. International Classes: C12N11/10;B01L3/00;G01N33/50 View Patent Images: Download PDF 20220282240 Primary Examiner: GIERE, REBECCA M Attorney, Agent or Firm: SBP Di...
Entity Name 企业名称 SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Entity Number 企业注册号 E0569352016-9 Tax ID 税号 - Status 企业状态 REGISTERED Formation / Incorporation Date 成立日期 - Registered Capital 注册资本 - Paid Capital 实缴资本 - Entity Type 企业类型 - QCC Code 企查查编码 QUSXF...
The present invention is based on the seminal discovery that BTLA agonist fusion proteins modulate an immune response. Specifically, the present invention provides fusion proteins that bind BTLA enhancing BTLA signaling. The present invention further provides methods of treating cancer and immune and ...
3 Questions on... What Cancer Algorithms Are Really Telling Us: With Adam Godzik, PhD, at Sanford Burnham Prebys Medical Discovery Institute, Godzik elaborated about why these findings are significant, and what they reveal about the future of using algorithms for cancer diagnoses....
Attorney, Agent or Firm: SANFORD BURNHAM PREBYS MEDICAL Claims: We claim: 1. An isolated peptide which selectively homes to heart vasculature, wherein said isolated peptide comprises CKRAVR(SEQ ID NO: 7). 2. The isolated peptide of claim 1, wherein said peptide consists of the amino acid ...
Sanford-Burnham Medical Research Institute (Sanford-Burnham) is the latest research organization to partner with Pfizer, Inc. as part of Pfizer's commitment to transforming research and development through a focus on translational medicine. The Centers f